TRAVATAN Z Rx
Generic Name and Formulations:
Travoprost 0.004%; oph soln; contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride).
Alcon Laboratories, Inc.
Indications for TRAVATAN Z:
Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension.
≥16yrs: 1 drop once daily in the PM.
<16yrs: not recommended.
Do not exceed recommended dose. Active intraocular inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk factors for macular edema. Benzalkonium chloride may be absorbed by contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy (Cat.C). Nursing mothers.
Allow at least 5mins between application of other topical ophthalmic agents.
Ocular hyperemia, decreased visual acuity, eye discomfort, pain or itching, foreign body sensation, other local reactions; increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent), other eyelash changes, abnormal vision, blepharitis, cataract, conjunctivitis, keratitis, photophobia, allergy, angina, bradycardia, headache.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Characteristics of Unipolar Mania, Distinct from Bipolar Disorder, Described
- Aspirin, N-Acetylcysteine Effective Adjunctive Treatments in Bipolar Depression
- Subthreshold Pediatric Bipolar Disorder Is a Significant Psychiatric Burden
- Interview-Only Version of Yale-Brown Obsessive-Compulsive Scale Effective for OCD Monitoring in Youth
- Potential Biomarker Differentiates Between Bipolar Disorder With, Without Psychosis
- Part 1: Adolescent Tech Use and Mental Health: Expert Roundtable
- Challenging Stigma: Should Psychiatrists Disclose Their Own Mental Illness?
- Social Anxiety in Schizophrenia: An Overlooked Problem
- Inflammation: Is It the Link Between Rheumatoid Arthritis and Depression?
- Childhood Physical Violence Associated With Decreased Total Cholesterol
- How the Government Shutdown Affects FDA Activities
- The Robot Will See You Now: The Increasing Role of Robotics in Psychiatric Care
- Extended-Release Naltrexone Improves Psychiatric Disorders During Addiction Therapy
- Infections, Antibiotics Associated With Subsequent Increased Risk for Mental Disorders in Youth